Clinical Trial Update: Comparative Effectiveness of Tirzepatide Versus Semaglutide in Individuals With Heart Failure With Preserved Ejection Fraction

View source ↗

Summary

A completed comparative effectiveness trial evaluated tirzepatide versus semaglutide in adults with type 2 diabetes and heart failure with preserved ejection fr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction
• Type 2 Diabetes Mellitus

Drugs mentioned

• MOUNJARO (tirzepatide)
• OZEMPIC (semaglutide)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Diabetes Mellitus, Type 2, HFpEF - Heart Failure With Preserved Ejection Fraction | Status: COMPLETED